AGES hysteroscopy-IVF trial

Not Applicable

• Conditions: Fertility-female

• Registration Number: PACTR201905470796922
• Lead Sponsor: IFE SPECIALIST HOSPITA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-05-07
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 770

Inclusion Criteria

All consenting infertile women, scheduled to start IVF or ICSI treatment.
Women having a normal transvaginal ultrasound of the uterine cavity (defined as no visible intracavitary pathology—eg, submucous myomas, polyps, or septa).

Exclusion Criteria

Women who will be planning cycles of preimplantation genetic testing.
Women with a diagnosis of a congenital or acquired uterine abnormality (such as a uterine malformation, adenomyosis, submucous myoma, or intrauterine adhesion).
Women with medical conditions that are contraindications to IVF procedures or pregnancy, such as uncontrolled hypertension, known symptomatic heart disease, poorly controlled type 1 or type 2 diabetes, undiagnosed liver disease or dysfunction, renal disease, severe anaemia, history of deep venous thrombosis, history of pulmonary embolus, previous cerebrovascular accident, or history of cervical cancer, endometrial cancer, or breast cancer.
Women who will be planning to undergo frozen embryo transfer.
Women with poor ovarian reserve using FSH of >9iu.

Study & Design

• Study Type: Interventional
• Study Design: Not specified